Market Trends of Infusion Pump Software Industry
This section covers the major market trends shaping the Infusion Pump Software Market according to our research experts:
Dose Error Reduction Software segment Holds Significant Share in Infusion Pump Software Market
- Though the patient safety is the major principle of health care, sometimes medication-related errors do exist and they have a significant impact. In 2017, the World Health Organization itself made it one of the main health challenges of our times to reduce medication errors by 50% within the next 5 years.
- In order to prevent the consequent harm, systems and procedures need to be put in place so that the right patient receives the right medication in the right dose, via the right means and at the right time, Hence, Dose Error Reduction Software (DERS) software is the key for ensuring patient safety as it offers advanced safety features for the infusion pumps and hence, it is estimated to grow significantly owing to the increasing number of medication errors occur while using infusion pumps.
- In August 2019, Baxter received CE marking of the EVO IQ Infusion System. The Evo IQ Infusion System features a scalable platform and user-centric design that includes an advanced drug library and dose error reduction software to promote patient safety.
Understand The Key Trends Shaping This Market
Download Sample
North America dominate the Global Infusion Pump Software Market
- The current growth of the North America infusion pump software market can be primarily attributed to home healthcare segment and patients and physicians, who are steadily adopting new technologically advanced products for regular treatment of chronic disease conditions.
- On the other side, the market is driven by increased patient awareness, growing prevalence of chronic diseases and increasing number of surgeries performed in the region and need to control escalating healthcare costs, infusion pump software market in the region has been experiencing a significant growth.
- According to the Journal of Infectious Disease Adviser, approximately 27 million surgical procedures are performed in the United States each year.
- In February 2019, Flowonix Medical, Inc. received the United States Food and Drug Administration (FDA) market approval for their Maestro Infusion Pump Software Upgrade for Clinician Programmers.
Get Analysis on Important Geographic Markets
Download Sample
